Neurocognitive impairment associated with predominantly early stage HIV infection in Abuja, Nigeria

详细信息    查看全文

• 作者：Christopher Akolo (2)
  Walter Royal III (1)
  Mariana Cherner (3)
  Kanayo Okwuasaba (4)
  Lindsay Eyzaguirre (2)
  Ruxton Adebiyi (4)
  Anya Umlauf (3)
  Terence Hendrix (3)
  Joyce Johnson (2)
  Alashl’e Abimiku (2)
  William A. Blattner (2)
  
• 关键词：Neuropsychological ; AIDS ; Africa
• 刊名：Journal of NeuroVirology
• 出版年：2014
• 出版时间：August 2014
• 年：2014
• 卷：20
• 期：4
• 页码：380-387
• 全文大小：166 KB
• 参考文献：1. (NACA), National Agency for the Control of AIDS (2012) Global AIDS response, Country progress report
  2. Anderson E, Zink W, Xiong H, Gendelman HE (2002) HIV-1-associated dementia: a metabolic encephalopathy perpetrated by virus-infected and immune-competent mononuclear phagocytes. J Acquir Immune Defic Syndr 31(Suppl 2):S43–S54 CrossRef
  3. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69:1789-799 CrossRef
  4. Berger JR, Moskowitz L, Fischl M, Kelley RE (1987) Neurologic disease as the presenting manifestation of acquired immunodeficiency syndrome. South Med J 80:683-86 CrossRef
  5. Carey CL, Woods SP, Gonzalez R, Conover E, Marcotte TD, Grant I, Heaton RK (2004) Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. J Clin Exp Neuropsychol 26:307-19 CrossRef
  6. Dore GJ, Correll PK, Li Y, Kaldor JM, Cooper DA, Brew BJ (1999) Changes to AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 13:1249-253 CrossRef
  7. Dore GJ, McDonald A, Li Y, Kaldor JM, Brew BJ (2003) Marked improvement in survival following AIDS dementia complex in the era of highly active antiretroviral therapy. AIDS 17:1539-545 CrossRef
  8. Ellis RJ, Deutsch R, Heaton RK, Marcotte TD, McCutchan JA, Nelson JA, Abramson I, Thal LJ, Atkinson JH, Wallace MR, Grant I (1997) Neurocognitive impairment is an independent risk factor for death in HIV infection. San Diego HIV Neurobehavioral Research Center Group. Arch Neurol 54:416-24 CrossRef
  9. Grant I, Atkinson JH, Hesselink JR, Kennedy CJ, Richman DD, Spector SA, McCutchan JA (1987) Evidence for early central nervous system involvement in the acquired immunodeficiency syndrome (AIDS) and other human immunodeficiency virus (HIV) infections. Studies with neuropsychologic testing and magnetic resonance imaging. Ann Intern Med 107:828-36 CrossRef
  10. Grant I, Heaton RK, Atkinson JH (1995) Neurocognitive disorders in HIV-1 infection. HNRC Group. HIV Neurobehavioral Research Center. Curr Top Microbiol Immunol 202:11-2
  11. Hall KS, Gao S, Emsley CL, Ogunniyi AO, Morgan O, Hendrie HC (2000) Community screening interview for dementia (CSI ‘D-; performance in five disparate study sites. Int J Geriatr Psychiatr 15:521-31 CrossRef
  12. Heaton RK, Franklin DR, Ellis RJ, McCutchan JA, Letendre SL, Leblanc S, Corkran SH, Duarte NA, Clifford DB, Woods SP, \Collier AC, Marra CM, Morgello S, Mindt MR, Taylor MJ, Marcotte TD, Atkinson JH, Wolfson T, Gelman BB, McArthur JC, Simpson DM, Abramson I, Gamst A, Fennema-Notestine C, Jernigan TL, Wong J, Grant I (2011) HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors. J Neurovirol 17:3-6 CrossRef
  13. Joska JA, GHPRSDFA (2010) Does highly active antiretroviral therapy improve neurocognitive function? A systematic review. 16
  14. Kanmogne GD, Kuate CT, Cysique LA, Fonsah JY, Eta S, Doh R, Njamnshi DM, Nchindap E, Franklin DR Jr, Ellis RJ, McCutchan JA, Binam F, Mbanya D, Heaton RK, Njamnshi AK (2010) HIV-associated neurocognitive disorders in sub-Saharan Africa: a pilot study in Cameroon. BMC Neurol 10:60 CrossRef
  15. Mayeux R, Stern Y, Tang MX, Todak G, Marder K, Sano M, Richards M, Stein Z, Ehrhardt AA, Gorman JM (1993) Mortality risks in gay men with human immunodeficiency virus infection and cognitive impairment. Neurology 43:176-82 CrossRef
  16. McArthur JC (1987) Neurologic manifestations of AIDS. Medicine (Baltimore) 66:407-37 CrossRef
  17. McArthur JC, Hoover DR, Bacellar H, Miller EN, Cohen BA, Becker JT, Graham NM, McArthur JH, Selnes OA, Jacobson LP (1993) Dementia in AIDS patients: incidence and risk factors. Multicenter AIDS Cohort Study. Neurology 43:2245-252 CrossRef
  18. Nath A (2002) Human immunodeficiency virus (HIV) proteins in neuropathogenesis of HIV dementia. J Infect Dis 186(Suppl 2):S193–S198 CrossRef
  19. Odiase F, Ogunrin O, Ogunniyi A (2006) Effect of progression of disease on cognitive performance in HIV/AIDS. J Natl Med Assoc 98:1260-262
  20. Paddick SM, Longdon AR, Kisoli A, Dotchin C, Gray WK, Dewhurst F, Chaote P, Kalaria R, Jusabani AM, Walker R (2013) Dementia prevalence estimates in sub-Saharan Africa: comparison of two diagnostic criteria. Glob Health Action 6:19646
  21. Report of a Working Group of the American Academy of Neurology AIDS Task Force (1991) Nomenclature and research case definitions for neurologic manifestations of human immunodeficiency virus-type 1 (HIV-1) infection. Report of a Working Group of the American Academy of Neurology AIDS Task Force. Neurology 41:778-85 CrossRef
  22. Royal W III, Cherner M, Carr J, Habib AG, Akomolafe A, Abimiku A, Charurat M, Farley J, Oluyemisi A, Mamadu I, Johnson J, Ellis R, McCutchan JA, Grant I, Blattner WA (2012) Clinical features and preliminary studies of virological correlates of neurocognitive impairment among HIV-infected individuals in Nigeria. J Neurovirol 18:191-99 CrossRef
  23. Sacktor N, Lyles RH, Skolasky R, Kleeberger C, Selnes OA, Miller EN, Becker JT, Cohen B, McArthur JC (2001) HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990-998. Neurology 56:257-60 CrossRef
  24. Salawu FK, Bwala SA, Wakil MA, Bani B, Bukbuk DN, Kida I (2008) Cognitive function in HIV-seropositive Nigerians without AIDS. J Neurol Sci 267:142-46 CrossRef
  25. Snider WD, Simpson DM, Nielsen S, Gold JW, Metroka CE, Posner JB (1983) Neurological complications of acquired immune deficiency syndrome: analysis of 50 patients. Ann Neurol 14:403-18 CrossRef
  26. UNAIDS (2012) Report on the Global AIDS epidemic
  
• 作者单位：Christopher Akolo (2)
  Walter Royal III (1)
  Mariana Cherner (3)
  Kanayo Okwuasaba (4)
  Lindsay Eyzaguirre (2)
  Ruxton Adebiyi (4)
  Anya Umlauf (3)
  Terence Hendrix (3)
  Joyce Johnson (2)
  Alashl’e Abimiku (2)
  William A. Blattner (2)
  
  2. The Institute of Human Virology at the University of Maryland School of Medicine, Baltimore, MD, USA
  1. Department of Neurology, University of Maryland School of Medicine, Baltimore, MD, 21201, USA
  3. HIV Neurobehavioral Research Center, University of California San Diego School of Medicine, La Jolla, CA, USA
  4. Institute of Human Virology-Nigeria, Abuja, Nigeria
  
• ISSN：1538-2443

文摘

Detailed neuropsychological testing was performed on 133 human immunodeficiency virus (HIV) seropositive (SP) and 77 HIV seronegative (SN) individuals, 86 % with early stage HIV infection in Nigeria, to determine the frequency of HIV-related neurocognitive impairment among the HIV-infected group. The tests were administered to assess the following seven ability domains: speed of information processing, attention/working memory, executive functioning, learning, memory, verbal fluency, and motor function motor. Demographically corrected individual test scores and scores for each domain or reflecting a global deficit (a global deficit score, or GDS) were compared for the SP and SN groups. SP participants were older, had fewer years of education, were more likely to be married, differed in ethnicity, and had higher depression scores than SN individuals. Within the seven ability domains, SP performed worse than SN with respect to speed of information processing, executive function, learning, memory, and verbal fluency and also on the global measure. SP were also more frequently impaired on tests of SIP, and there was a borderline increase in the frequency of global impairment. On the individual tests, SP performed worse than SN on four tests that assessed learning, verbal fluency, memory, and motor function (the Timed Gait). SP subjects, however, performed better than SN on the Finger-tapping test, also a motor task. Performance by SP subjects was not associated on the timed gait which showed a borderline statistically significant correlation with CD4 counts. However, there were significant correlations between viral load measurements and individual tests of speed of information processing, executive function, learning, and verbal fluency and with overall executive function and a borderline correlation with the GDS. Depression scores for SP were associated with impairment on only a single test of executive function. These results demonstrate the ability of these assessments to identify areas of impairment that may be specifically linked to a history of HIV infection among individuals in Nigeria. Confirmation of these findings awaits analyses using data from a larger number of control subjects.